Msh3 and Pms1 Set Neuronal CAG-repeat Migration Rate to Drive Selective Striatal and Cortical Pathogenesis in HD Mice
Nan Wang,
No information about this author
Shasha Zhang,
No information about this author
Peter Langfelder
No information about this author
et al.
Published: July 13, 2024
SUMMARY
Modifiers
of
Huntington’s
disease
(HD)
include
mismatch
repair
(MMR)
genes;
however,
their
underlying
disease-altering
mechanisms
remain
unresolved.
Knockout
(KO)
alleles
for
9
HD
GWAS
modifiers/MMR
genes
were
crossed
to
the
Q140
Huntingtin
(mHtt)
knock-in
mice
probe
such
mechanisms.
Four
KO
strongly
(
Msh3
and
Pms1
)
or
moderately
Msh2
Mlh1
rescue
a
triad
adult-onset,
striatal
medium-spiny-neuron
(MSN)-selective
phenotypes:
somatic
Htt
DNA
CAG-repeat
expansion,
transcriptionopathy,
mHtt
protein
aggregation.
Comparatively,
cortex
also
exhibits
an
analogous,
but
later-onset,
pathogenic
that
is
-dependent.
Remarkably,
Q140/homozygous
Msh3-KO
lacks
visible
aggregates
in
brain,
even
at
advanced
ages
(20-months).
Moreover,
-deficiency
prevents
synaptic
marker
loss,
astrogliosis,
locomotor
impairment
mice.
Purified
MSN
nuclei
exhibit
highly
linear
age-dependent
repeat
expansion
(i.e.
migration),
with
modal-CAG
increasing
+8.8
repeats/month
(R
2
=0.98).
This
rate
reduced
2.3
0.3
heterozygous
homozygous
alleles,
respectively.
Our
study
defines
thresholds
below
which
there
are
no
detectable
nuclear
neuropil
aggregates.
Mild
transcriptionopathy
can
still
occur
stabilized
140-CAG
repeats,
majority
transcriptomic
changes
due
expansion.
analysis
reveals
479
expression
levels
correlated
length
MSNs.
Thus,
our
mechanistically
connects
selective
neuronal
vulnerability
HD,
set
migration
drive
repeat-length
dependent
pathogenesis;
provides
preclinical
platform
targeting
these
suppression
across
brain
regions.
One
Sentence
Summary
genetic
drivers
sequential
cortical
pathogenesis
by
mediating
vulnerable
neurons.
Language: Английский
Sex Differences in a Novel Mouse Model of Spinocerebellar Ataxia Type 1 (SCA1)
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(6), P. 2623 - 2623
Published: March 14, 2025
Spinocerebellar
ataxia
type
1
(SCA1)
is
a
rare
autosomal
dominant
inherited
neurodegenerative
disease
caused
by
the
expansion
of
glutamine
(Q)-encoding
CAG
repeats
in
gene
ATAXIN1
(ATXN1).
Patients
with
SCA1
suffer
from
movement
and
cognitive
deficits
severe
cerebellar
pathology.
Previous
studies
identified
sex
differences
progression
patients,
but
whether
these
are
present
mouse
models
unclear.
Using
battery
behavioral
tests,
immunohistochemistry
brain
slices,
RNA
sequencing,
we
examined
motor
performance,
pathology,
expression
changes
recently
created
conditional
knock-in
model
f-ATXN1146Q
expressing
human
coding
regions
ATXN1
146
repeats.
We
found
worse
performance
weight
loss
accompanied
increased
microglial
activation
an
increase
immune
viral
response
pathways
male
mice.
Language: Английский
Uncontrolled CAG expansion in neurons susceptible to Huntington's disease
The Lancet Neurology,
Journal Year:
2025,
Volume and Issue:
24(4), P. 282 - 284
Published: March 20, 2025
Language: Английский
An expanded polyglutamine in ATAXIN1 results in a loss-of-function that exacerbates severity of Multiple Sclerosis in an EAE mouse model
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 14, 2025
Abstract
Background
and
Objectives
Ataxin-1
(ATXN1)
is
a
protein
in
which
expansion
of
its
polyglutamine
tract
causes
the
neurodegenerative
disorder
spinocerebellar
ataxia
type
1
(SCA1)
via
gain-of-function.
Wild
ATXN1
was
recently
shown
to
have
protective
role
regulating
severity
experimental
autoimmune
encephalomyelitis
(EAE),
well-established
mouse
model
for
Multiple
sclerosis
(MS).
This
study
further
investigates
with
an
expanded
context
MS
using
EAE
model.
Methods
Hemizygous
Atxn1
(Atxn12Q/−)
mice
or
f-
ATXN1146Q/2Q,
heterozygous
that
one
copy
endogenous
gene
replaced
polyQ
pathogenic
human
ATXN1
gene,
were
injected
myelin
oligodendrocytes
glycoprotein
(MOG
35
−
55)
peptide
induce
EAE.
Immunohistochemical
biochemical
approaches
used
analyze
degree
demyelination,
cell
loss,
axonal
degeneration
as
well
detecting
activated
immune
cells
inflammatory
cytokines
upon
induction
Atxn12Q/−
f-
ATXN1146Q/2Q
mice.
Results
Our
findings
reveal
loss-of-function
wild
Atxn1
f-ATXN1146Q/2Q
significantly
exacerbates
symptoms,
leading
increased
heightened
axon
degeneration,
greater
clinical
disability
affected
Importantly,
data
reveals
neurotoxic
astrocytes
are
at
acute
stage
disease
(PID-14)
chronic
(PID-30)
no
longer
show
signs
activation.
The
also
demonstrated
enhanced
infiltration
into
lesions
mutant
Discussion
These
results
indicate
plays
modulating
responses
maintaining
neural
integrity
during
MS.
ATXN1’s
ability
dampen
response.
Understanding
functional
pathogenesis
may
open
new
avenues
therapeutic
strategies
aimed
mitigating
progression.
Language: Английский
A Neural Basis for Mutant ATAXIN-1 Induced Respiratory Dysfunction in Mouse Models of Spinocerebellar Ataxia Type 1
Alyssa Soles,
No information about this author
Jessica Grittner,
No information about this author
Kaia Douglas
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 20, 2024
Abstract
Spinocerebellar
ataxia
type
1
(SCA1),
a
dominantly
inherited
neurodegenerative
disorder
caused
by
an
expanded
trinucleotide
repeat
in
the
ATAXIN-1
(ATXN1)
gene,
is
characterized
motor
dysfunction,
cognitive
impairment,
and
death
from
compromised
swallowing
respiration.
To
delineate
specific
cell
types
that
contribute
to
respiratory
we
utilized
floxed
conditional
knock-in
f-ATXN1
146Q/2Q
mouse.
Whole
body
plethysmography
during
spontaneous
respiration
challenge
showed
mice
exhibit
phenotype
elevated
frequency,
volumes,
output.
Consequently,
ability
of
increase
ventilation
impaired.
investigate
role
mutant
ATXN1
expression
neural
skeletal
muscle
lineages,
were
bred
Nestin-Cre
Acta1-Cre
respectively.
These
analyses
revealed
abnormal
involved
two
aspects:
behavioral
which
SCA1
increased
activity
testing
functional
dysregulation
central
control
centers.
Both
aspects
partially
ameliorated
removing
neural,
but
not
muscle,
lineages.
Language: Английский